Nova One Advisor
Global Keratoconus treatment Market Size, Share, Forecast Report, 2020-2027

Global Keratoconus treatment Market Size, Share, Forecast Report, 2020-2027

Status: Published Category: Healthcare Insight Code: 2750 Format: PDF / PPT / Excel

Content

Keratoconus is a progressive eye disorder. In this condition, cornea thins and begins to bulge outward into a cone-like shape and causes distorted or blurred vision, increased sensitivity to bright light or glare, sudden clouding of vision etc.

Development of technologically advanced diagnostic and treatment products, growing awareness, increasing healthcare expenditure, and rising demand from emerging regions are driving the growth for global keratoconus treatment market.

Global keratoconus treatment market is expected to grow at the CAGR of ~4.1% during the forecast period and is estimated to reach USD 427.5 million by 2023.
Segments:

Global keratoconus treatment market has been segmented on the basis of type which comprises of forme fruste keratoconus, corneal hydrops, keratoglobus, pellucid marginal degeneration, posterior keratoconus, and others.

On the basis of diagnosis, the market is segmented into computerized corneal mapping, keratometry, slit-lamp examination, refraction test, and others. Slit-lamp examination includes tonometry, vision testing, and others.

On the basis of treatments, the market has been segmented into lenses, surgery, collagen cross-linking, and others. Lenses is sub-segmented into eyeglasses or soft contact lenses, hard contact lenses, piggyback lenses, hybrid lenses, scleral lenses, and others. Surgery is sub-segmented into corneal inserts, cornea transplant, and others. Collagen cross-linking is still in research process and more study is required to implement this treatment option.

On the basis of end user, it is segmented into eye hospitals & clinics, medical research centers, academic institutes, and others.
Key players for global keratoconus treatment market:

Some of the key players in this market are: Bausch & Lomb Incorporated (US), CIBA VISION (US), CooperVision (US), HOYA Vision Care (Singapore), Johnson & Johnson Vision Care, Inc. (US), Menicon Co., Ltd. (Japan), Novartis AG (Switzerland), Optik Seis (Indonesia), and SAFILENS S.R.L. (Italy), and others.

  • Insight Code: 2750
  • No. of Pages: 250
  • Format: PDF/PPT/Excel
  • Published: July 2020
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034